Patents
Sitemap › C07 - Organic chemistry › C07D - Heterocyclic compounds › C07D 271 - Heterocyclic compounds containing five-membered rings having two nitrogen atoms and one oxygen atom as the only ring hetero atoms
Patents for C07D 271 - Heterocyclic compounds containing five-membered rings having two nitrogen atoms and one oxygen atom as the only ring hetero atoms (7,144)
09/2010
09/29/2010EP1638928B1 N-alkynyl-2-(substituted aryloxy)alkylthioamide derivatives as fungicides
09/28/2010US7803938 3-{[4-(4-acetyl-3-hydroxy-2-propylphenoxymethyl)-phenyl]-(S)-hydroxymethyl}-benzoic acid; anxiolytic, neuroleptic agent and antidepressant as glutamate receptor agonist; antiinflammatory agent as leukotriene receptor agonist;
09/28/2010CA2383524C Thiazolyl alkynyl compounds and methods of use thereof
09/23/2010WO2010107984A1 Novel alpha-(n-sulfonamido)acetamide compounds incorporating deuterium as inhibitors of beta amyloid peptide production a novel alpha-(n-sulfonamido) acetamide compound incorporating deuterium as inhibitor of beta amyloid peptide production
09/23/2010US20100240902 Oxadiazole Derivative, Light-Emitting Element Material, Light-Emitting Element, Light-Emitting Device, and Electronic Device
09/23/2010US20100240719 Novel alpha-(n-sulfonamido)acetamide compounds incorporating deuterium as inhibitors of beta amyloid peptide production
09/23/2010US20100240708 Alpha-(N-Benzenesulfonamido)Cycloalkyl Derivatives
09/23/2010US20100240659 Nitrogen-containing heterocyclic derivative having 11ss-hydroxysteroid dehydrogenase type i inhibitory activity
09/23/2010US20100240658 Oxadiazole Derivatives
09/23/2010US20100240622 Nitric oxide enhancing prostaglandin compounds, compositions and methods of use
09/23/2010US20100240617 Bicyclic sphingosine 1-phosphate analogs
09/23/2010US20100237773 Carbazole Derivative with Heteroaromatic Ring, and Light-Emitting Element, Light-Emitting Device, and Electronic Device Using Carbazole Derivative with Heteroaromatic Ring
09/21/2010US7799812 Reverse isoxazoles
09/21/2010CA2444123C Novel arylsulfonamides as antiviral agents
09/21/2010CA2436225C N-(arylsulphonyl)beta-amino acid derivatives comprising a substituted aminomethyl group, process for preparing them and pharmaceutical compositions containing them
09/16/2010WO2010105179A2 Inhibitors of beta-secretase
09/16/2010US20100234435 Cycloalkylamino acid derivatives
09/16/2010US20100234404 P-38 Kinase Inhibitors
09/15/2010EP2228364A1 Acylsulfonamides as inhibitors of steroid sulfatase
09/15/2010CN101835763A Oxadiazolidinedione compound
09/14/2010US7795283 Oxadiazole derivative as DGAT inhibitors
09/14/2010US7795260 ecteinascidin analogues used for the treatment of of leukaemia, lung cancer, colon cancer, kidney cancer, melanoma, prostate cancer, ovarian cancer, breast cancer, pancreatic epitheloid carcinoma, and cervix epitheloid carcinoma; antitumor and anticarcinogenic agents
09/10/2010CA2753730A1 Inhibitors of beta-secretase
09/08/2010EP2225196A1 Cysteine protease inhibitors for the treatment of parasitic diseases
09/08/2010CN1850812B Imidazole derivative, and its preparing method and use for pharmaceutical for tubercle bacillus
09/07/2010US7790754 such as (2R) N-((1R)-1-{5-[5-chloro-3-fluoro-2-(5-methyl-1,2,4-oxadiazol-3-yl)phenyl]-3-fluoropyridin-2-yl}ethyl)-3,3,3-trifluoro-2-hydroxy-2-methylpropanamide, useful in the treatment or prevention of symptoms such as pain and inflammation; analgesics and antiinflammatory agents
09/02/2010WO2010097372A1 Compounds as bradykinin b1 antagonists
09/02/2010US20100221699 Amine-n-oxide redox indicators for fluorimetric determination of analytes
09/02/2010CA2759126A1 New compounds
09/01/2010EP2222669A1 Oxadiazole derivatives active on sphingosine-1-phosphate (sip)
09/01/2010CN101817799A Cyanoacrylate compound and application thereof in pesticide and medicine
08/2010
08/31/2010US7786122 use to treat Alzheimer's Disease; (2R)-2-[N-(4-Chlorobenzenesulfonyl)-N-(4-methoxybenzyl)amino]-4-methylpentanoic acid amide for example
08/26/2010WO2010066682A4 Compounds, pharmaceutical composition and methods for use in treating metabolic disorders
08/26/2010WO2010019772A3 Oxadiazole-2-oxides as antischistosomal agents
08/26/2010US20100216851 1,2,4-oxadiazole benzoic acid compositions and their use in bioassays
08/25/2010CN101815707A oxadiazole diaryl compounds
08/25/2010CN101812059A Nitric oxide donor-type farnesyl thiosalicylic acid derivative, and preparation method and medical application thereof
08/25/2010CN101812034A 2-substituent-5-(2,4-dichlorophenyl)-1,3,4-oxadiazole derivative, synthetic method and application thereof
08/24/2010US7781470 Aminodicarboxylic acid derivatives having pharmaceutical properties
08/24/2010US7781460 isoxazoline indazoles derivatives, such as 3-(1-Cyclopentyl-1H-indazol-6-yl)-5-methyl-4,5-dihydroisoxazole-5-carbonitrile, useful in the treatment of nervous system, respiratory system and skin disoders, AIDS, shock,, Crohn's disease, granuloma, vision defects and inflammatory diseases
08/19/2010US20100210694 New no-donor aspirin derivatives
08/19/2010US20100210603 Novel sulfonamide inhibitors of aspartyl protease
08/19/2010CA2752190A1 Small molecule bradykinin b1 receptor antagonists
08/18/2010CN101809007A Novel fluorescent derivatives of polyamine, method for preparing same and applications thereof as diagnosis tools in the treatment of cancerous tumours
08/18/2010CN101805338A Oxadiazole-based piperazine derivative and application thereof
08/17/2010CA2547591C Novel compounds and compositions as cathepsin inhibitors
08/17/2010CA2527203C Casr antagonist
08/12/2010WO2010090304A1 Acylguanidine derivative
08/12/2010US20100204288 Heteroaryl-Ureas and Their Use as Glucokinase Activators
08/12/2010US20100202975 Novel fluorescent derivatives of polyamines, method for preparing same and applications thereof as diagnosis tools in the treatment of cancerous tumors
08/11/2010EP2216330A1 Oxadiazolidinedione compound
08/11/2010EP2215049A1 P2x3, receptor antagonists for treatment of pain
08/10/2010US7772425 Vitamin D receptor modulators
08/10/2010US7772285 Benzophenone derivatives or salts thereof
08/10/2010US7772259 1,2,4-Oxadiazole benzoic acid compounds and their use for nonsense suppression and the treatment of disease
08/05/2010WO2010087430A1 N-acyl anthranilic acid derivative or salt thereof
08/05/2010WO2010086551A1 Thiadiazole and oxadiazole derivatives, preparation thereof, and therapeutic use thereof
08/05/2010WO2010045303A3 Pyrrolidine, piperidine and piperazine derivatives and methods of use thereof
08/05/2010US20100197749 Chemical compounds
08/05/2010US20100197696 Pesticidal heterocyclic dihaloallyl compounds
08/05/2010US20100197644 Chemical Compounds 572
08/05/2010CA2750742A1 Thiadiazole and oxadiazole derivatives, preparation thereof, and therapeutic use thereof
08/05/2010CA2750452A1 N-acyl anthranilic acid derivative or salt thereof
08/04/2010EP2212284A2 Calcium receptor modulating agents
08/04/2010EP1392660B1 Substituted benzoylcyclohexenones and their use as herbicidal agents
08/03/2010US7767706 Substituted aryl acylthioureas and related compounds; inhibitors of viral replication
08/03/2010CA2402199C Amidino compounds useful as nitric oxide synthase inhibitors
07/2010
07/29/2010US20100187978 Material for organic electro-optical device having fluorene derivative compound and organic electro-optical device including the same
07/28/2010EP2209771A1 Cyclobutyl carboxylic acid derivatives
07/27/2010US7763732 Indole derivatives
07/22/2010WO2010083404A2 Linked myc-max small molecule inhibitors
07/22/2010WO2010081877A1 Nitric oxide furoxan derivative compounds endowed with antitumoral activity
07/22/2010WO2010081488A1 Nitric oxide furoxan derivative compounds endowed with antitumoral activity
07/22/2010US20100184813 Chemical compounds 553
07/22/2010US20100184601 Method and Means Relating to Multiple Herbicide Resistance in Plants
07/22/2010US20100183712 Acylated indanyl amines and their use as pharmaceuticals
07/21/2010CN101784535A Novel dicarboxylic acid derivatives as S1P1 receptor agonists
07/20/2010US7759493 agonists of G-protein coupled receptor 40 (GPR40), useful for the treatment of non-insulin dependent diabetes, obesity and lipid disorders, such as diabetic dyslipidemia, hyperlipidemia, hypercholesterolemia, and hypertriglyceridemia
07/20/2010CA2486399C Calcium receptor modulating agents
07/14/2010EP2205575A1 A novel alpha-(n-sulfonamido)acetamide compound as an inhibitor of beta amyloid peptide production
07/14/2010CN101774938A Type of capsaicine derivative, preparation method thereof and medical use thereof
07/13/2010US7754743 Heteroarylcarbamoylbenzene derivatives
07/13/2010US7754726 Benzamide derivatives as p-38 kinase inhibitors
07/08/2010US20100173958 Compounds for the inhibition of dgat1 activity
07/08/2010US20100173933 Antibacterial agents
07/07/2010EP2203219A1 Substituted benamidines as antibacterial agents
07/07/2010CN101768138A Organic micro-molecular film containing protonized nitrogen atoms and preparation method thereof
07/01/2010WO2010045258A3 Spirocyclic gpr40 modulators
07/01/2010US20100168190 Novel azoles and related derivatives as non-nucleoside reverse transcriptase inhibitors (nnrtis) in antiviral therapy (hiv)
07/01/2010US20100168109 Pharmaceutical compositions of 1,2,4-oxadiazole benzoic acid and their use for the treatment of disease
06/2010
06/30/2010EP2200967A2 New no-donor aspirin derivatives
06/29/2010US7745465 Antiischemic agents; antiinflammatory agents; antiallergens; autoimmune disease
06/24/2010WO2010070343A1 1,3,4-oxadiazole derivatives and their uses to treat diabetes
06/24/2010WO2010005958A3 1,2,5-oxadiazoles as inhibitors of indoleamine 2,3-dioxygenase
06/24/2010US20100160632 Bisamid-zinkbasen
06/24/2010CA2747306A1 1,3,4-oxadiazole derivatives and their uses to treat diabetes
06/23/2010CN101747289A Chemical compounds containing triphenylamine units and oxadiazole units, and application thereof
06/22/2010US7741352 for the treatment or alleviation of pain, headaches, nervous system disorders or trauma, stroke, neurodegenerative diseases, cardiovascular disorders, inflammatory diseases, vision defects, hearing disorders, respiratory system disordres and urinary incontinence
06/22/2010US7741347 Hepatitis C virus inhibitors
06/17/2010WO2010066682A1 Compounds, pharmaceutical composition and methods for use in treating metabolic disorders
1 ... 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 ... 72